 | • レポートコード：MRC2Q12-19241 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、モダフィニルのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 モダフィニルのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 モダフィニルの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 モダフィニルのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのモダフィニルの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のモダフィニルの売上および2028年までの予測に焦点を当てています。 モダフィニルのグローバル主要企業には、Welman Pharma、Orion、Acino、Teva、Alembic Pharma、Apotex、Appco Pharma、Arrow Pharma、Ascent Innovative Medicines、Auro Laboratories、Aurobindo Pharma、Cadila Pharma、Sun Pharma、Cephalon、Chanelle Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 モダフィニル市場は、タイプとアプリケーションによって区分されます。世界のモダフィニル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 100Mg、200Mg 【アプリケーション別セグメント】 ナルコレプシー、多発性硬化症（MS） 疲労感 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - モダフィニル製品概要 - タイプ別市場（100Mg、200Mg） - アプリケーション別市場（ナルコレプシー、多発性硬化症（MS） 疲労感） - 調査の目的 ・エグゼクティブサマリー - 世界のモダフィニル販売量予測2017-2028 - 世界のモダフィニル売上予測2017-2028 - モダフィニルの地域別販売量 - モダフィニルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別モダフィニル販売量 - 主要メーカー別モダフィニル売上 - 主要メーカー別モダフィニル価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（100Mg、200Mg） - モダフィニルのタイプ別販売量 - モダフィニルのタイプ別売上 - モダフィニルのタイプ別価格 ・アプリケーション別市場規模（ナルコレプシー、多発性硬化症（MS） 疲労感） - モダフィニルのアプリケーション別販売量 - モダフィニルのアプリケーション別売上 - モダフィニルのアプリケーション別価格 ・北米市場 - 北米のモダフィニル市場規模（タイプ別、アプリケーション別） - 主要国別のモダフィニル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのモダフィニル市場規模（タイプ別、アプリケーション別） - 主要国別のモダフィニル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のモダフィニル市場規模（タイプ別、アプリケーション別） - 主要国別のモダフィニル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のモダフィニル市場規模（タイプ別、アプリケーション別） - 主要国別のモダフィニル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのモダフィニル市場規模（タイプ別、アプリケーション別） - 主要国別のモダフィニル市場規模（トルコ、サウジアラビア） ・企業情報 Welman Pharma、Orion、Acino、Teva、Alembic Pharma、Apotex、Appco Pharma、Arrow Pharma、Ascent Innovative Medicines、Auro Laboratories、Aurobindo Pharma、Cadila Pharma、Sun Pharma、Cephalon、Chanelle Medical ・産業チェーン及び販売チャネル分析 - モダフィニルの産業チェーン分析 - モダフィニルの原材料 - モダフィニルの生産プロセス - モダフィニルの販売及びマーケティング - モダフィニルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - モダフィニルの産業動向 - モダフィニルのマーケットドライバー - モダフィニルの課題 - モダフィニルの阻害要因 ・主な調査結果 |
Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Modafinil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Modafinil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Modafinil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Modafinil include Welman Pharma, Orion, Acino, Teva, Alembic Pharma, Apotex, Appco Pharma, Arrow Pharma and Ascent Innovative Medicines, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Modafinil manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Modafinil market. Further, it explains the major drivers and regional dynamics of the global Modafinil market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Welman Pharma
Orion
Acino
Teva
Alembic Pharma
Apotex
Appco Pharma
Arrow Pharma
Ascent Innovative Medicines
Auro Laboratories
Aurobindo Pharma
Cadila Pharma
Sun Pharma
Cephalon
Chanelle Medical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by specs and by application segments based on sales, price, and value for the period 2017-2028.
Modafinil Segment by Specs
100Mg
200Mg
Modafinil Segment by Application
Narcolepsy
Multiple Sclerosis (MS) Fatigue
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Modafinil market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Modafinil, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Modafinil, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Modafinil, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Modafinil sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Modafinil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Modafinil sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Welman Pharma, Orion, Acino, Teva, Alembic Pharma, Apotex, Appco Pharma, Arrow Pharma and Ascent Innovative Medicines, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Modafinil in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Modafinil manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by specs, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by specs, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by specs, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by specs, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by specs, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Modafinil sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Modafinil Product Introduction
1.2 Market by Specs
1.2.1 Global Modafinil Market Size Growth Rate by Specs, 2017 VS 2021 VS 2028
1.2.2 100Mg
1.2.3 200Mg
1.3 Market by Application
1.3.1 Global Modafinil Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Narcolepsy
1.3.3 Multiple Sclerosis (MS) Fatigue
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Modafinil Sales Estimates and Forecasts 2017-2028
2.2 Global Modafinil Revenue Estimates and Forecasts 2017-2028
2.3 Global Modafinil Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Modafinil Sales by Region
2.4.1 Global Modafinil Sales by Region (2017-2022)
2.4.2 Global Sales Modafinil by Region (2023-2028)
2.5 Global Modafinil Revenue by Region
2.5.1 Global Modafinil Revenue by Region (2017-2022)
2.5.2 Global Modafinil Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Modafinil Sales by Manufacturers
3.1.1 Global Top Modafinil Manufacturers by Sales (2017-2022)
3.1.2 Global Modafinil Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Modafinil in 2021
3.2 Global Modafinil Revenue by Manufacturers
3.2.1 Global Modafinil Revenue by Manufacturers (2017-2022)
3.2.2 Global Modafinil Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Modafinil Revenue in 2021
3.3 Global Modafinil Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Modafinil Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Modafinil Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specs
4.1 Global Modafinil Sales by Specs
4.1.1 Global Modafinil Historical Sales by Specs (2017-2022)
4.1.2 Global Modafinil Forecasted Sales by Specs (2023-2028)
4.1.3 Global Modafinil Sales Market Share by Specs (2017-2028)
4.2 Global Modafinil Revenue by Specs
4.2.1 Global Modafinil Historical Revenue by Specs (2017-2022)
4.2.2 Global Modafinil Forecasted Revenue by Specs (2023-2028)
4.2.3 Global Modafinil Revenue Market Share by Specs (2017-2028)
4.3 Global Modafinil Price by Specs
4.3.1 Global Modafinil Price by Specs (2017-2022)
4.3.2 Global Modafinil Price Forecast by Specs (2023-2028)
5 Market Size by Application
5.1 Global Modafinil Sales by Application
5.1.1 Global Modafinil Historical Sales by Application (2017-2022)
5.1.2 Global Modafinil Forecasted Sales by Application (2023-2028)
5.1.3 Global Modafinil Sales Market Share by Application (2017-2028)
5.2 Global Modafinil Revenue by Application
5.2.1 Global Modafinil Historical Revenue by Application (2017-2022)
5.2.2 Global Modafinil Forecasted Revenue by Application (2023-2028)
5.2.3 Global Modafinil Revenue Market Share by Application (2017-2028)
5.3 Global Modafinil Price by Application
5.3.1 Global Modafinil Price by Application (2017-2022)
5.3.2 Global Modafinil Price Forecast by Application (2023-2028)
6 North America
6.1 North America Modafinil Market Size by Specs
6.1.1 North America Modafinil Sales by Specs (2017-2028)
6.1.2 North America Modafinil Revenue by Specs (2017-2028)
6.2 North America Modafinil Market Size by Application
6.2.1 North America Modafinil Sales by Application (2017-2028)
6.2.2 North America Modafinil Revenue by Application (2017-2028)
6.3 North America Modafinil Market Size by Country
6.3.1 North America Modafinil Sales by Country (2017-2028)
6.3.2 North America Modafinil Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Modafinil Market Size by Specs
7.1.1 Europe Modafinil Sales by Specs (2017-2028)
7.1.2 Europe Modafinil Revenue by Specs (2017-2028)
7.2 Europe Modafinil Market Size by Application
7.2.1 Europe Modafinil Sales by Application (2017-2028)
7.2.2 Europe Modafinil Revenue by Application (2017-2028)
7.3 Europe Modafinil Market Size by Country
7.3.1 Europe Modafinil Sales by Country (2017-2028)
7.3.2 Europe Modafinil Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Modafinil Market Size by Specs
8.1.1 Asia Pacific Modafinil Sales by Specs (2017-2028)
8.1.2 Asia Pacific Modafinil Revenue by Specs (2017-2028)
8.2 Asia Pacific Modafinil Market Size by Application
8.2.1 Asia Pacific Modafinil Sales by Application (2017-2028)
8.2.2 Asia Pacific Modafinil Revenue by Application (2017-2028)
8.3 Asia Pacific Modafinil Market Size by Region
8.3.1 Asia Pacific Modafinil Sales by Region (2017-2028)
8.3.2 Asia Pacific Modafinil Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Modafinil Market Size by Specs
9.1.1 Latin America Modafinil Sales by Specs (2017-2028)
9.1.2 Latin America Modafinil Revenue by Specs (2017-2028)
9.2 Latin America Modafinil Market Size by Application
9.2.1 Latin America Modafinil Sales by Application (2017-2028)
9.2.2 Latin America Modafinil Revenue by Application (2017-2028)
9.3 Latin America Modafinil Market Size by Country
9.3.1 Latin America Modafinil Sales by Country (2017-2028)
9.3.2 Latin America Modafinil Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Modafinil Market Size by Specs
10.1.1 Middle East and Africa Modafinil Sales by Specs (2017-2028)
10.1.2 Middle East and Africa Modafinil Revenue by Specs (2017-2028)
10.2 Middle East and Africa Modafinil Market Size by Application
10.2.1 Middle East and Africa Modafinil Sales by Application (2017-2028)
10.2.2 Middle East and Africa Modafinil Revenue by Application (2017-2028)
10.3 Middle East and Africa Modafinil Market Size by Country
10.3.1 Middle East and Africa Modafinil Sales by Country (2017-2028)
10.3.2 Middle East and Africa Modafinil Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Welman Pharma
11.1.1 Welman Pharma Corporation Information
11.1.2 Welman Pharma Overview
11.1.3 Welman Pharma Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Welman Pharma Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Welman Pharma Recent Developments
11.2 Orion
11.2.1 Orion Corporation Information
11.2.2 Orion Overview
11.2.3 Orion Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Orion Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Orion Recent Developments
11.3 Acino
11.3.1 Acino Corporation Information
11.3.2 Acino Overview
11.3.3 Acino Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Acino Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Acino Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Alembic Pharma
11.5.1 Alembic Pharma Corporation Information
11.5.2 Alembic Pharma Overview
11.5.3 Alembic Pharma Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Alembic Pharma Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Alembic Pharma Recent Developments
11.6 Apotex
11.6.1 Apotex Corporation Information
11.6.2 Apotex Overview
11.6.3 Apotex Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Apotex Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Apotex Recent Developments
11.7 Appco Pharma
11.7.1 Appco Pharma Corporation Information
11.7.2 Appco Pharma Overview
11.7.3 Appco Pharma Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Appco Pharma Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Appco Pharma Recent Developments
11.8 Arrow Pharma
11.8.1 Arrow Pharma Corporation Information
11.8.2 Arrow Pharma Overview
11.8.3 Arrow Pharma Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Arrow Pharma Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Arrow Pharma Recent Developments
11.9 Ascent Innovative Medicines
11.9.1 Ascent Innovative Medicines Corporation Information
11.9.2 Ascent Innovative Medicines Overview
11.9.3 Ascent Innovative Medicines Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ascent Innovative Medicines Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ascent Innovative Medicines Recent Developments
11.10 Auro Laboratories
11.10.1 Auro Laboratories Corporation Information
11.10.2 Auro Laboratories Overview
11.10.3 Auro Laboratories Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Auro Laboratories Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Auro Laboratories Recent Developments
11.11 Aurobindo Pharma
11.11.1 Aurobindo Pharma Corporation Information
11.11.2 Aurobindo Pharma Overview
11.11.3 Aurobindo Pharma Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Aurobindo Pharma Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Aurobindo Pharma Recent Developments
11.12 Cadila Pharma
11.12.1 Cadila Pharma Corporation Information
11.12.2 Cadila Pharma Overview
11.12.3 Cadila Pharma Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Cadila Pharma Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Cadila Pharma Recent Developments
11.13 Sun Pharma
11.13.1 Sun Pharma Corporation Information
11.13.2 Sun Pharma Overview
11.13.3 Sun Pharma Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Sun Pharma Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sun Pharma Recent Developments
11.14 Cephalon
11.14.1 Cephalon Corporation Information
11.14.2 Cephalon Overview
11.14.3 Cephalon Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Cephalon Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Cephalon Recent Developments
11.15 Chanelle Medical
11.15.1 Chanelle Medical Corporation Information
11.15.2 Chanelle Medical Overview
11.15.3 Chanelle Medical Modafinil Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Chanelle Medical Modafinil Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Chanelle Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Modafinil Industry Chain Analysis
12.2 Modafinil Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Modafinil Production Mode & Process
12.4 Modafinil Sales and Marketing
12.4.1 Modafinil Sales Channels
12.4.2 Modafinil Distributors
12.5 Modafinil Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Modafinil Industry Trends
13.2 Modafinil Market Drivers
13.3 Modafinil Market Challenges
13.4 Modafinil Market Restraints
14 Key Findings in The Global Modafinil Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer